Skip to main content

Table 2 Cancer excluded from secondary endpoint all cancer risk

From: Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol

Men (cancers excluded)

Women (cancers excluded)

Non-melanoma skin cancer

Non-melanoma skin cancer

Breast

Prostate

Ovarian

Male genital organs

Endometrial

 

Female genital organs

 
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us